Press Release
Seattle, WA – February 3, 2026 – RevealDx, a leader in AI tools for the characterization of lung nodules, announced FDA clearance of RevealAI-Lung. The company had previously announced MDR Certification in November of 2025. The RevealDx...
OptraSCAN: AI-powered digital pathology solution for AFB detection & bacillary grading at scale to support treatment response assessment and follow-up workflows. SAN JOSE, CA, UNITED STATES, February 5, 2026 /EINPresswire.com/...
Proscia: 100% of customers interviewed would buy again, citing trust for primary diagnosis at scale and a partnership they can count on PHILADELPHIA – February 4, 2026 – Proscia®, a software company advancing digital pathology for...
February 2, 2026 at 10:00 a.m. EET. Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia® Gastric Cancer AI application is...
Philips is recognized for its market-leading innovation and comprehensive digital pathology ecosystem, driving global transformation in diagnostics and healthcare informatics SAN ANTONIO, Jan. 29, 2026 /PRNewswire/ -- Frost &...
CancerIQ and Azra: Partnership aligns risk-based patient engagement, LDCT screening, and AI-powered imaging follow-up as lung programs scale CHICAGO and NASHVILLE, Tenn., Jan. 26, 2026 /PRNewswire/ -- CancerIQ, a precision health platform...
